Walley T - Search Results

1

Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trial.

Avorn J, Benner J, Ford I, Ganz DA, Gaw A, Glynn RJ, Jackson J, Lagaay AM, Schneeweiss S, Walley T, Wang PS; Outcomes Research Working Group and the PROSPER Study Group. Avorn J, et al. Among authors: walley t. Control Clin Trials. 2002 Dec;23(6):757-73. doi: 10.1016/s0197-2456(02)00228-3. Control Clin Trials. 2002. PMID: 12505250

2

A randomized trial of Evidence-based OutReach (EBOR): rationale and design.

Freemantle N, Eccles M, Wood J, Mason J, Nazareth I, Duggan C, Young P, Haines A, Drummond M, Russell I, Walley T. Freemantle N, et al. Among authors: walley t. Control Clin Trials. 1999 Oct;20(5):479-92. doi: 10.1016/s0197-2456(99)00023-9. Control Clin Trials. 1999. PMID: 10503808 Clinical Trial.

3

Cost effectiveness of lowering cholesterol. Study did not take account of confounders.

Haycox A, Barton S, Walley T. Haycox A, et al. Among authors: walley t. BMJ. 1996 Nov 2;313(7065):1142-3; author reply 1144. doi: 10.1136/bmj.313.7065.1142b. BMJ. 1996. PMID: 8916708 Free PMC article. No abstract available.

4

Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation.

Dündar Y, Boland A, Strobl J, Dodd S, Haycox A, Bagust A, Bogg J, Dickson R, Walley T. Dündar Y, et al. Among authors: walley t. Health Technol Assess. 2004 Jun;8(24):iii-x, 1-125. doi: 10.3310/hta8240. Health Technol Assess. 2004. PMID: 15193209 Free article. Review.

5

Registration of noncommercial randomised clinical trials: the feasibility of using trial registries to monitor the number of trials.

Raftery J, Fairbank E, Douet L, Dent L, Price A, Milne R, Walley T. Raftery J, et al. Among authors: walley t. Trials. 2012 Aug 20;13:140. doi: 10.1186/1745-6215-13-140. Trials. 2012. PMID: 22906196 Free PMC article.

6

The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature.

Hughes DA, Bagust A, Haycox A, Walley T. Hughes DA, et al. Among authors: walley t. Health Econ. 2001 Oct;10(7):601-15. doi: 10.1002/hec.609. Health Econ. 2001. PMID: 11747044 Review.

7

Economic evaluation under managed competition: evidence from the U.K.

Drummond M, Cooke J, Walley T. Drummond M, et al. Among authors: walley t. Soc Sci Med. 1997 Aug;45(4):583-95. doi: 10.1016/s0277-9536(96)00398-x. Soc Sci Med. 1997. PMID: 9226783

8

Pharmacoeconomics: integrating economic evaluation into clinical trials.

Haycox A, Drummond M, Walley T. Haycox A, et al. Among authors: walley t. Br J Clin Pharmacol. 1997 Jun;43(6):559-62. doi: 10.1046/j.1365-2125.1997.00576.x. Br J Clin Pharmacol. 1997. PMID: 9205814 Free PMC article. Review. No abstract available.

9

Economic evaluations of drug therapy: attitudes of primary care prescribing advisers in Great Britain.

Walley T, Barton S, Cooke J, Drummond M. Walley T, et al. Health Policy. 1997 Jul;41(1):61-72. doi: 10.1016/s0168-8510(97)00013-4. Health Policy. 1997. PMID: 10169062

10

The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review.

Hockenhull JC, Dwan KM, Smith GW, Gamble CL, Boland A, Walley TJ, Dickson RC. Hockenhull JC, et al. Crit Care Med. 2009 Feb;37(2):702-12. doi: 10.1097/CCM.0b013e3181958915. Crit Care Med. 2009. PMID: 19114884 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

239 results

Search Page